Formulation and method for treating skeletal muscle...

Details Formulation and method for treating skeletal muscle... Formulation and method for treating skeletal muscle...

2005-05-03

2005-05-03

Lankford, Jr, Leon B. (Department: 1651)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

Containing or obtained from leguminosae

C424S725000, C426S629000, C426S590000, C514S027000, C514S456000

Reexamination Certificate

active

06887499

ABSTRACT:
A formulation is provided for the treatment of the adverse affects of skeletal muscle degenerative diseases prevalent in humans in developing countries. The formulation typically includes a first component including at least one of jasmone, a jasmonate, jasmonic acid, oxo-phytodienoic acid, and a second component including at least one of an antioxidant and carnitine. Additionally, soy milk may be utilized as a delivery vehicle for the formulation for oral ingestion by a subject. The formulation is designed to replenish energy levels in disease infected muscle cells, reinstate calcium homeostasis within the muscle cells, and reduce the activity of oxidizing free radical reactions typically caused by muscle degenerative diseases.

REFERENCES:
patent: 6465021 (2002-10-01), Bababunmi
patent: 20030096375 (2003-05-01), Smith et al.

Affiliated with

Also associated with

Rating

Formulation and method for treating skeletal muscle... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulation and method for treating skeletal muscle..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation and method for treating skeletal muscle... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3434565